Treatment – Hormonal Therapies
Written by: Ina Fried and Heather Morse | Last reviewed: December 2020
- Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm. Front Med (Lausanne). 2020 Mar 4;7:68. doi:10.3389/fmed.2020.00068.
- Nesbitt E, Clements S, Driscoll M. A concise clinician’s guide to therapy for hidradenitis suppurativa. Int J Womens Dermatol. 2020 Mar;6(2):80-84. doi:10.1016/j.ijwd.2019.11.004.
- Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and polycystic ovarian syndrome: systematic review and meta-analysis. Australasian Journal of Dermatology. 2020;61:e28-e33. doi:10.1111/ajd.13110.
- Vossen AR, van Straalen KR, Prens EP, van der Zee HH. Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study. J Am Acad Dermatol 2017;76(1):155-156.
- Perng P, Zampella JG, Okoye G. Management of hidradenitis suppurativa in pregnancy. J Am Acad Dermatol . 2017 May;76(5):979-989. doi:10.1016/j.jaad.2016.10.032.
- Riis PT, Ring HC, Themstrup L, Jemec GB. The role of androgens and estrogens in hidradenitis suppurativa - a systematic review. Acta Dermatovenerol Croat. 2016 Dec;24(4):239-249. Available at https://pubmed.ncbi.nlm.nih.gov/28128074/. Accessed 7/9/2020.
- Kromann CB, Deckers IE, Esmann S, et al. Risk-factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014 Oct;171(4):819-824. doi:10.1111/bjd.13090.
- Clark AK, Quinonez RL, Saric S, Sivamani RK. Hormonal therapies for hidradenitis suppurativa: Review. Dermatol Online J. 2017;23(10):13030/qt6383k0n4.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91‐101.
- Khandalavala BN, Do MV. Finasteride in hidradenitis suppurativa: a ‘‘male’’ therapy for a predominantly ‘‘female’’ disease. J Clin Aesthet Dermatol. 2016 June;9(6):44-50. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928456/. Accessed 8/19/2020.
- Lowes M, Hoffman L. Faculty opinions recommendation of [Lee A, Fischer G. A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol. 2015;56(3):192-196]. In Faculty Opinions. doi:10.3410/f.726985760.793525572.
- Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Jan;29(4):619-644. doi:10.1111/jdv.12966.
- Ngan V. Polycystic ovarian syndrome. Topics A-Z. DermNet NZ. 2003. Available at https://www.dermnetnz.org/topics/polycystic-ovary-syndrome/. Accessed 7/17/2020.
- Dictionary definition: metabolic syndrome. National Institute of Diabetes and Digestive and Kidney Diseases. Available at https://www.niddk.nih.gov/Dictionary/M/metabolic-syndrome. Accessed 7/21/2020.
- Verdolini R, Clayton N, Smith A, et al. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27:1101-1108. doi:10.1111/j.1468-3083.2012.04668.x.